A Two Part Phase II Open Label Study on the effects of Denosumab in modifying disease activity in patients with Diabetes Mellitus and Charcot Neuropathic Osteoarthropathy.
Latest Information Update: 20 Sep 2019
At a glance
- Drugs Denosumab (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- Acronyms 2 POD-C
- 28 Jul 2017 Status changed from not yet recruiting to recruiting.
- 18 Jun 2014 New trial record